Cargando…
Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes
CONTEXT: Metabolomics has the potential to generate biomarkers that can facilitate understanding relevant pathways in the pathophysiology of type 2 diabetes (T2DM). METHODS: Nontargeted metabolomics was performed, via liquid chromatography–mass spectrometry, in a discovery case-cohort study from the...
Autores principales: | Ottosson, Filip, Smith, Einar, Gallo, Widet, Fernandez, Céline, Melander, Olle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804288/ https://www.ncbi.nlm.nih.gov/pubmed/31502646 http://dx.doi.org/10.1210/jc.2019-00822 |
Ejemplares similares
-
Plasma Metabolites Associate with All-Cause Mortality in Individuals with Type 2 Diabetes
por: Ottosson, Filip, et al.
Publicado: (2020) -
The association between plasma metabolites and future risk of all‐cause mortality
por: Yan, Yingxiao, et al.
Publicado: (2022) -
Altered Acylcarnitine Metabolism Is Associated With an Increased Risk of Atrial Fibrillation
por: Smith, Einar, et al.
Publicado: (2020) -
Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
por: Gallo, Widet, et al.
Publicado: (2021) -
Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality
por: Ottosson, Filip, et al.
Publicado: (2019)